E-cadherin down-regulation is considered to be a key event during EMT, as demonstrated in vivo and in different cancer cell lines, including lung, breast, colorectal, and ovarian cancer [26,27,28]. This evidence concerns the gene CDH1 and ovarian carcinoma.